Characteristics and outcome of patients with acute myeloid leukaemia and t(8.16)(p11.p13): results from an International Collaborative Study*

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F21%3A00013205" target="_blank" >RIV/00023736:_____/21:00013205 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11150/21:10428580 RIV/65269705:_____/21:00074339 RIV/00179906:_____/21:10428580 RIV/00098892:_____/21:N0000162 RIV/00216224:14110/21:00120102
Result on the web
<a href="https://doi.org/10.1111/bjh.17336" target="_blank" >https://doi.org/10.1111/bjh.17336</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1111/bjh.17336" target="_blank" >10.1111/bjh.17336</a>

Result language
angličtina
Original language name
Characteristics and outcome of patients with acute myeloid leukaemia and t(8.16)(p11.p13): results from an International Collaborative Study*
Original language description
In acute myeloid leukaemia (AML) t(8.16)(p11.p13)/MYST3-CREBBP is a very rare abnormality. Previous small series suggested poor outcome. We report on 59 patients with t(8.16) within an international, collaborative study.
Czech name
—
Czech description
—

Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30205 - Hematology

Project
<a href="/en/project/NV15-25809A" target="_blank" >NV15-25809A: National study of leukemia cell mutations and clonality in patients diagnosed with acute myeloid leukemia</a><br>
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year
2021
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)